ClinicalTrials.gov
ClinicalTrials.gov Menu

Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01070745
Recruitment Status : Withdrawn (Changes in approach to PDA therapy)
First Posted : February 18, 2010
Last Update Posted : June 7, 2012
Sponsor:
Information provided by:
Shaare Zedek Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2012
  Study Completion Date : No date given